The ability of artificial intelligence to predict life expectancy in oncology is the ‘holy grail’ of the sector. Panellists discussed this and where else AI is having an impact on complex care at HBI 2020.
To a remarkable extent, hospitals CEOs whether in Europe, China or Emerging Markets share the same goals around extending their patient offering forwards into primary and back into chronic and rehabilitation using digital health to achieve this. And the one thing they all know they need to get right is culture.
Most of the ongoing research into healthcare AI is in the clinical space. However, there are plenty of non-clinical tasks, like the protocols and positioning of MRIs, in which AI can boost productivity by 30-50%.
The EBITDA of one of Asia's largest hospital consolidators grew 60% through the COVID-19 pandemic, its executive chairman Vishal Bali said at HBI 2020, as the group "skinned" out a lot of operating costs.
The IFC said at HBI 2020 that medical tourism in emerging markets is unlikely to normalise until the end of 2021. Providers say they are already doubling and tripling plans to build in domestic markets, rather than bringing patients to tourism hubs.
Ping An and Teladoc revealed their plans for global expansion at HBI 2020. The former says it's hard to leave such a big domestic market as China but has sights set on SE Asia and 'the developing world'. Teladoc is focused on Europe, Brazil and also on Ping An's home turf, China! Both are now capable of delivering full acuity care and have driven their insights using some of healthcare's largest datasets.
Investors from varied backgrounds - infrastructure, private equity, and REIT, are all bullish about the prospects for healthcare investment in 2021, according to a panel of experts speaking at the HBI 2020 European Investment Panel discussion. But the pandemic may have 'readjusted the relative value discussion across sectors' according to one private equity investor.
The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.
Elsan and Mehilainen, top-two private hospital operators in France and Finland respectively, and both CVC portfolio companies, say their in-house investments in digitalising the patient pathway have increased customer loyalty, cross-selling revenues and insurer-funded work. They were joined by GE Healthcare for the 'Hospitals: The journey towards digital and outpatient transformation' session at HBI 2020.
There is a crisis in access to treatment in the UK as private and NHS waiting lists soar, said panellists at the 'State of the Region: The UK' at HBI 2020.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
